Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

Conditions: Pancreatic Cancer; Pancreatic Neoplasms; Pancreatic Ductal Adenocarcinoma (PDAC); Pancreatic Lesions Located at the Body or the Tail
Interventions: Device: ARTIDIS ART-1 Device
Sponsors: ARTIDIS AG; H. Lee Moffitt Cancer Center and Research Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 22, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments